Scalable human ES culture for therapeutic use: Propagation, differentiation, genetic modification and regulatory issues

Gene Therapy

Volumn 15, Issue 2, 2008, Pages 82-88

  Rao, M ^a  

^a INVITROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTEGRASE; PRESERVATION SOLUTION; TRANSPOSASE; XENOBIOTIC AGENT; ZINC FINGER PROTEIN;

BIOEQUIVALENCE; CELL CULTURE; CELL DIFFERENTIATION; CELL MANIPULATION; CELL POPULATION; CELL SELECTION; CULTURE MEDIUM; CULTURE OPTIMIZATION; DNA MODIFICATION; EMBRYONIC STEM CELL; EX VIVO GENE TRANSFER; EXPERIMENTAL ANIMAL; GENE INSERTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GENOME ANALYSIS; GOOD MANUFACTURING PRACTICE; HOMOLOGOUS RECOMBINATION; HUMAN; LEGAL ASPECT; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL GENE THERAPY;

ANIMALS; CELL CULTURE TECHNIQUES; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; LEGISLATION, MEDICAL; MODELS, ANIMAL; STEM CELL TRANSPLANTATION; UNITED STATES;

EID: 37749014948     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303061     Document Type: Review

References (46)

1. Zeng X, Rao MS. Embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience 2007; 145: 1348-1358.
2. Allegrucci C, Young LE. Differences between human embryonic stem cell lines. Hum Reprod Update 2007; 13: 103-120.
3. Strulovici Y, Leopold PL, O'Connor TP, Pergolizzi RG, Crystal RG. Human embryonic stem cells and gene therapy. Mol Ther 2007; 15: 850-866.
4. Carpenter MK, Rosler E, Rao MS. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003; 5: 79-88.
5. Mallon BS, Park KY, Chen KG, Hamilton RS, McKay RD. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 2006; 38: 1063-1075.
6. Andrews PW, Benvenisty N, McKay R, Pera MF, Rossant J, Semb H et al. Steering Committee of the International Stem Cell Initiative. The International Stem Cell Initiative: Toward benchmarks for human embryonic stem cell research. Nat Biotechnol 2005; 23: 795-797.
7. Pyle AD, Lock LF, Donovan PJ. Neurotrophins mediate human embryonic stem cell survival. Nat Biotechnol 2006; 24: 344-350.
8. Ellerstrom C, Strehl R, Noaksson K, Hyllner J, Semb H. Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells 2007; 25: 1690-1696.
9. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 91: 501-508.
10. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 2001; 172: 383-397.
11. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694-4705.
12. Wilson PG, Stice SS. Development and differentiation of neural rosettes derived from human embryonic stem cells. Stem Cell Rev 2007; 2 67-77.
13. Carpenter M, Rao MS, Freed W, Zeng X. Derivation and characterization of neuronal precursors and dopaminergic neurons from human embryonic stem cells in vitro. Methods Mol Biol 2006; 331: 153-167.
14. Filipczyk AA, Passier R, Rochat A, Mummery CL. Cardiovascular development: Towards biomediRal applicability: regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci 2007; 64: 704-718.
15. Lees JG, Tuch BE. Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny. Regen Med 2006; 1: 327-336.
16. Reems JA, Fujita D, Tyler T, Moldwin R, Smith SD. Obtaining an accepted investigational new drug application to operate an umbilical cord blood bank. Transfusion 1999; 39: 357-363.
17. Loring JF, Rao MS. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 2006; 24: 145-150.
18. Bondanza A, Ciceri F, Bonini C. Application of donor lymphocytes expressing a suicide gene for early GVL induction and later control of GVH reactions after bone-marrow transplantation. Methods Mol Med 2005; 109: 475-486.
19. Bonini C, Bondanza A, Perna SK, Kaneko S, Traversari C, Ciceri F et al. The suicide gene therapy challenge: How to improve a successful gene therapy approach. Mol Ther 2007, 15: 1248-1252.
20. Wiley RG. Targeting toxins to neural antigens and receptors. Methods Mol Biol 2001; 166: 267-276.
21. Ren X, Tahimic CG, Katoh M, Kurimasa A, Inoue T, Oshimura M. Human artificial chromosome vectors meet stem cells: New prospects for gene delivery. Stem Cell Rev 2006; 2: 43-50.
22. Pochampally RR, Horwitz EM, DiGirolamo CM, Stokes DS, Prockop DJ. Correction of a mineralization defect by over-expression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: A strategy for rescuing mutations that produce dominant-negative protein defects. Gene Therapy 2005; 12: 1119-1125.
23. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003; 21: 319-321.
24. Urbach A, Schuldiner M, Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 2004; 22: 635-641.
25. Liu Y, Song Z, Zhao Y, Qin H, Cai J, Zhang H et al. A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 2006; 346: 131-139.
26. Lu J, Hou R, Booth CJ, Yang SH, Snyder M. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103 5688-5693.
27. Yao S, Chen S, Clark J, Hao E, Beattie GM, Hayek A et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 2006; 103: 6907-6912.
28. Stewart MH, Bosse M, Chadwick K, Menendez P, Bendall SC, Bhatia M. Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods 2006; 3: 807-815.
29. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005; 435: 646-651.
30. Moehle EA, Rock JM, Lee YL, Jouvenot Y, Dekelver RC, Gregory PD et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 2007; 104: 3055-3060.
31. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 2001; 21: 3926-3934.
32. Belteki G, Gertsenstein M, Ow DW, Nagy A. Site-specific cassette exchange and germline transndssion with mouse ES cells expressing phiC31 integrase. Nat Biotechnol 2003; 21: 321-324.
33. Ehrhardt A, Engler JA, Xu H, Cherry AM, Kay MA. Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Hum Gene Ther 2007; 17: 1077-1094.
34. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91: 501-510.
35. Fischer SE, Wenholds E, Plasterk RH. Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci USA 2001; 98: 6759-6764.
36. Hackett PB, Ekker SC, Largaespada DA, McIvor RS. Sleeping beauty transposon mediated gene therapy for prolonged expression. Adv Genet 2005; 54: 189-232.
37. Wilson MH, Coates CJ, George Jr AL. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 2007; 15: 139-145.
38. Loring JF, Rao MS. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 2006; 24: 145-150.
39. Zeng X, Rao MS. The therapeutic potential of embryonic stem cells. a focus on stem cell stability. Curr Opin Mol Ther 2006; 8: 338-344.
40. Ginis I, Rao MS. Toward cell replacement therapy: Promises and caveats. Exp Neurol 2003; 184: 61-77.
41. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005; 37: 1099-1103.
42. Hentze H, Graichen R, Colman A. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 2007; 25: 24-32.
43. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.
44. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007; 25: 1177-1181.
45. Kanatsu-Shinohara M, Inoue Y, Lee J, Yushimoto M, Ogonuki N, Miki H et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004; 119: 1001-1012.
46. Kerr CL, Shamblott MJ, Gearhart JD. Pluripotent stem cells from germ cells. Methods Enzymol 2006; 419: 400-426.